Trade Brand of Technology: A trade name for idarucizumab has not yet been finalized. 4. Brief Description of Service, Device or Drug:.
Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Other names, BI- . AHFS/Drugs.com
Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by
The approval of the antidote, known by the brand name Praxbind and the generic name idarucizumab, makes Pradaxa the first in its class of new
Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab
The use of idarucizumab in patients with a known hypersensitivity to idarucizumab or any brand name of their DOAC. What their DOAC is used
Brand Name Sort descending Generic Name Therapeutic Area Recommendation Type Idarucizumab (Drug Plan Submission), Reversal of dabigatran
Generic name: idarucizumab systemic. Brand names: Praxbind. Reviewed by Medicine.com on Febru. Consumer; Health Professional. On this page.
Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim - Wikipedia.
Comments
Not my kink but well written!